Zevra Therapeutics

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31
Revenue
$3,695
$4,449
$3,425
Gross Profit
1,392
876
160
EBITDA
-29,296
-16,183
-14,395
EBIT
-30,913
-17,745
-15,957
Net Income
-33,225
-19,925
-16,622
Net Change In Cash
3,695
4,449
3,425
Free Cash Flow
-18,141
-19,109
-16,165
Cash
54,039
39,260
42,849
Basic Shares
47,808
41,899
41,778

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$27,461
$10,458
$28,650
$13,288
Gross Profit
24,516
10,115
26,591
11,983
EBITDA
-48,598
-25,526
-7,888
-5,431
EBIT
-49,604
-26,470
-8,145
-5,704
Net Income
-46,049
-41,543
-8,555
-12,760
Net Change In Cash
27,461
10,458
28,650
13,288
Free Cash Flow
-33,830
-18,810
10,337
-1,972
Cash
43,049
65,466
112,346
4,213
Basic Shares
35,452
34,488
29,766
3,980

Earnings Calls

Quarter EPS
2024-09-30
-$0.69
2024-06-30
-$0.48
2024-03-31
-$0.40
2023-12-31
-$0.40